Related references
Note: Only part of the references are listed.Exploiting the Mutanome for Tumor Vaccination
John C. Castle et al.
CANCER RESEARCH (2012)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
TIL therapy broadens the tumor-reactive CD8+ T cell compartment in melanoma patients
Pia Kvistborg et al.
ONCOIMMUNOLOGY (2012)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes
Dalibor Blazek et al.
GENES & DEVELOPMENT (2011)
Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia
Juliette J. Kahle et al.
HUMAN MOLECULAR GENETICS (2011)
Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules
Benoit Guillaume et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Sian Jones et al.
SCIENCE (2010)
Augmin: a protein complex required for centrosome-independent microtubule generation within the spindle
Gohta Goshima et al.
JOURNAL OF CELL BIOLOGY (2008)
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Mark E. Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence
Morten Nielsen et al.
PLOS ONE (2007)
Patterns of somatic mutation in human cancer genomes
Christopher Greenman et al.
NATURE (2007)
Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation
J Chapiro et al.
JOURNAL OF IMMUNOLOGY (2006)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Persistence of multiple tumor-specific T-Cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy
JH Zhou et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
Axin-mediated CKI phosphorylation of β-catenin at Ser 45:: a molecular switch for the Wnt pathway
S Amit et al.
GENES & DEVELOPMENT (2002)
Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells
S Morel et al.
IMMUNITY (2000)